切换至 "中华医学电子期刊资源库"
高级检索
中华老年骨科与康复电子杂志

中华老年骨科与康复电子杂志 ›› 2022, Vol. 08 ›› Issue (01) : 35 -43. doi: 10.3877/cma.j.issn.2096-0263.2022.01.007

Meta分析

抗骨吸收药对骨修复的影响：一项随机对照研究的系统综述和meta分析
付海瑞1, 杨露阳2, 梁斌3, 刘强4,†()   
  1. 1. 030032　山西省太原市山西医科大学附属白求恩医院骨科；032200　山西省吕梁市汾阳市山西医科大学附属汾阳医院骨科
    2. 030001　山西省太原市山西医科大学第一医院内分泌科
    3. 032200　山西省吕梁市汾阳市山西医科大学附属汾阳医院骨科
    4. 030032　山西省太原市山西医科大学附属白求恩医院骨科
  • 收稿日期:2020-08-25 出版日期:2022-02-05
  • 通信作者: 刘强

Effect of anti-resorptive agents affect on bone repair. A meta-analysis of randomized controlled studies

Hairui Fu1, Luyang Yang2, Bin Liang3, Qiang Liu4,†()   

  1. 1. Department of Orthopedics, Affiliated Bethune Hospital of Shanxi Medical University, Taiyuan 030032, China; Department of Orthopedics, Affiliated Fenyang Hospital of Shanxi Medical University, Fenyang 032200, China
    2. Endocrinology Department, The First Hospital of Shanxi Medical University, Taiyuan 030001, China
    3. Department of Orthopedics, Affiliated Fenyang Hospital of Shanxi Medical University, Fenyang 032200, China
    4. Department of Orthopedics, Affiliated Bethune Hospital of Shanxi Medical University, Taiyuan 030032, China
  • Received:2020-08-25 Published:2022-02-05
  • Corresponding author: Qiang Liu
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

付海瑞, 杨露阳, 梁斌, 刘强. 抗骨吸收药对骨修复的影响：一项随机对照研究的系统综述和meta分析[J/OL]. 中华老年骨科与康复电子杂志, 2022, 08(01): 35-43.

Hairui Fu, Luyang Yang, Bin Liang, Qiang Liu. Effect of anti-resorptive agents affect on bone repair. A meta-analysis of randomized controlled studies[J/OL]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2022, 08(01): 35-43.

目的

旨在明确骨修复的炎症期或骨生成期使用抗骨吸收药是否会影响骨修复。

方法

检索MEDLINE，EMBASE，CENTRAL和中国生物医学文献数据库，检索时间为自建库至2020年12月19日。研究的纳入标准为使用抗骨吸收药与骨修复关系的所有相关临床随机对照研究。纳入研究的质量评价使用5.2版本的Cochrane偏倚风险评估工具，使用Review Manager 5.4.1软件进行数据合成。其中，使用风险比（RR）及其95%的置信区间（CI）作为效应量，使用Mantel-Haenszel法和固定效应模型进行分析。

结果

最终确认符合纳入标准的相关研究25个，有18个研究纳入meta分析，包含3 421例，合成的骨连接RR=1.013（95% CI：0.994，1.032，P=0.198）。敏感性分析中，排除11个非低风险研究后的骨连接RR=1.008（95% CI：0.987，1.029，P=0.475）。亚组分析中，四肢骨折愈合人群（9个研究，2 891例）的骨连接RR=1.009（95% CI：0.989，1.029，P=0.399）；脊柱融合人群（9个研究，530例）的骨连接RR=1.034（95% CI：0.979，1.091，P=0.230）；骨质疏松患者人群（13个研究，749例）的骨连接RR=1.038（95% CI：0.993，1.086，P=0.103）；内固定手术人群（15个研究，2 967例）的骨连接RR=1.005（95% CI：0.989，1.021，P=0.540）。各研究结果均包括无效值1，即骨修复早期使用抗骨吸收药不影响骨连接。

结论

通过该研究可见，在骨修复的炎症期或骨生成期应用抗骨吸收药并不影响骨连接。其中，无论四肢骨折患者或脊柱融合手术患者，无论骨质疏松患者，或经历内固定手术患者，在骨修复早期应用抗骨吸收药预防继发性骨质疏松性骨折均不影响骨连接。因此，对于适用抗骨质疏松治疗的患者，出现骨折后建议立即开始抗骨质疏松治疗。

关键词: 抗骨吸收药, 骨连接, 脊柱融合, 骨折愈合, meta分析
Objective

The meta-analysis was performed to determine whether the early use of the anti-resorptive drugs would affect bone union.

Methods

We searched MEDLINE, EMBASE, CENTRAL and CBM for the related studies from each database inception until December 19, 2020. The inclusion criteria were all relevant clinical randomized controlled studies that studied the relationship between the anti-resorptive drugs and bone union. We assessed the quality of the included studies with version 5.2 of the Cochrane risk-of-bias tool, and the software for data synthesis was Review Manager 5.4.1. The effect measure was risk ratio (RR) with 95% confidence interval (CI), the Mantel-Haenszel method and the fixed effect model were used to analyze data.

Results

25 studies met the inclusion criteria, 18 studies were included in the meta-analysis, including 3, 421 people, the total bone union RR=1.013(95% CI: 0.994, 1.032, P=0.198). In the sensitivity analysis of excluding 11 non-low-risk studies, RR=1.008 (95% CI: 0.987, 1.029, P=0.475). In the subgroup analysis, the limb fracture population(9 studies, 2, 891 persons), RR= 1.009 (95% CI: 0.989, 1.029, P=0.399); the spinal fusion population (9 studies, 530 persons), RR=1.034 (95% CI: 0.979, 1.091, P=0.230), the osteoporotic population (13 studies, 749 persons), RR=1.038 (95% CI: 0.993, 1.086, P=0.103); the internal fixation surgery population (15 studies, 2,967 persons), RR=1.005 (95% CI: 0.989, 1.021, P=0.540). The results of each analysis included an invalid value of 1, that is, the early use of the anti-resorptive drugs in bone repair did not affect bone union.

Conclusions

In general, the early application of the anti-resorptive drugs in bone repair does not affect bone union. Among them, no matter the limb fracture patients or the spinal fusion patients, whether the osteoporotic patients, or the patients undergoing internal fixation surgery, the use of the anti-resorptive drugs in the early stage of bone repair to prevent secondary osteoporosis fracture does not affect bone union. Therefore, for patients suitable for anti-osteoporosis treatment, it is recommended to start anti-osteoporosis treatment immediately after fracture.

Key words: The anti-resorptive drugs, Bone union, Spinal fusion, Fracture healing, Meta-analysis
图1 研究筛选流程图
表1 纳入研究特点表
研究编码 国家 OP 骨折部位 手术/方法 实验组（人） 对照组（人） 干预 对照
高勇2017[37] 中国 是 转子间 ORIF/PFNA 15 15 ALN 空白
Colón-Emeric 2011[33] 美国 否 髋部 手术方法由治疗医生决定 1 065 1 062 ZOL 安慰剂
Duckworth 2019[30] 英国 否 桡骨远端 由经治医生决定手术或保守 196 183 ALN 安慰剂
Gong 2012[36] 韩国 是 桡骨远端 ORIF/掌侧板 24 26 ALN ALN（术后3月执行）
Harding 2011[32] 瑞典 否 胫骨平台近端截骨 HCO/外固定架 25 21 ZOL 安慰剂
Kim 2012[35] 韩国 是 转子间 加压螺钉或髓内钉（由术者决定） 47 24 RIS RIS（术后3月执行）
Nagahama 2011[34] 日本 是 腰椎融合 PLIF/双Cage+椎间隙植骨/自体骨和磷酸三钙 19 17 ALN 维生素D
van der Poest 2000[46] 荷兰 是 桡骨远端 否 18 19 ALN 安慰剂
van der Poest 2002[31] 荷兰 否 下肢 由经治医生决定手术或保守 20 18 ALN 安慰剂
研究编码 干预执行时间 干预持续时间（月） 评估时间 实验组骨连接（人） 对照组骨连接（人）
高勇2017[37] 10~14天 12 3月 10 9
Colón-Emeric 2011[33] 90天内 36 至少6周 1031 1033
Duckworth 2019[30] 14天内 6 8周 121 103
Gong 2012[36] 14天 - 10周 24 26
Harding 2011[32] 4周 12 12周 24 20
Kim 2012[35] 1周或1月 12 12周 35 15
Nagahama 2011[34] 1周 12 12月 18 11
van der Poest 2000[46] 平均4~5周 12 - 18 18
van der Poest 2002[31] 2周 12 - 19 17
Yang 2018[38] 中国 是 拇外翻行近节趾骨截骨、跖跗关节融合 螺钉固定 56 57 ZOL
陈莹2019[43] 中国 是 腰椎融合 PLIF/Cage/自体骨 31 32人 ZOL
李辉南2016[41] 中国 是 腰椎融合 PLIF/自体骨 20 18 ZOL
刘汉辉2019[44] 中国 是 腰椎融合 TLIF 32 30 ZOL
潘晟2014[40] 中国 是 腰椎融合 PLIF 40 40 ZOL
尹自龙2020[45] 中国 是 颈椎融合 前路/异体骨 28 29 ZOL
Chen 2016[27] 中国 是 腰椎融合 PLIF/自体骨+异体骨 33 36 ZOL
Li 2012[39] 中国 否 腰椎融合 TLIF/Cage/自体骨 41人 41人 ZOL
Liu 2019[42] 中国 是 颈椎融合 ACDF/Cage/异体骨 21 22 ZOL
Yang 2018[38] 安慰剂 1周 6 12周 56 57
陈莹2019[43] 空白 1周 12 - 27* 28*
李辉南2016[41] 空白 1~2周 12 - 20 16
刘汉辉2019[44] 空白 第5天 12 12月 29 28
潘晟2014[40] 空白 第7天 12 - 40 39
尹自龙2020[45] 安慰剂 第2~3天 12 12月 28 29
Chen 2016[27] 安慰剂 3天 12 12月 27 30
Li 2012[39] 安慰剂 3天 12 12月 36 35
Liu 2019[42] 安慰剂 第5天 12 12月 21 22
图8 手术患者骨连接风险比
1
Kanis JA, Svedbom A, Harvey N, et al. The osteoporosis treatment gap [J]. J Bone Miner Res, 2014, 29(9): 1926-1928.
2
Russell R, Watts NB, Ebetino FH, et al. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy [J]. Osteoporos Int, 2008, 19(6): 733-759.
3
Mcclung MR, Lewiecki EM, Cohen SB, et al. Denosumab in postmenopausal women with low bone mineral density [J]. N Engl J Med, 2006, 354(8): 821-831.
4
Marsell R, Einhorn TA. The biology of fracture healing [J]. Injury, 2011, June, 42(6): 551-555.
5
Isaksson H. Recent advances in mechanobiological modeling of bone regeneration [J]. Mech Res Commun, 2012, 42: 22-31.
6
Claes L, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions [J]. Nat Rev Rheumatol, 2012, 8(3): 133-143.
7
Féron JM, Mauprivez R. Fracture repair: general aspects and influence of osteoporosis and anti-osteoporosis treatment [J]. Injury, 2016, 47(Suppl 1): S10-S14.
8
Schell H, Lienau J, Epari DR, et al. Osteoclastic activity begins early and increases over the course of bone healing [J]. Bone, 2006, 38(4): 547-554.
9
Kates SL, Ackert-Bicknell CL. How do bisphosphonates affect fracture healing? [J]. Injury, 2016, 47(Suppl 1): S65-S68.
10
Savaridas T, Wallace RJ, Salter DM, et al. Do bisphosphonates inhibit direct fracture healing? [J]. Bone Joint J, 2013, 95-B(9): 1263.
11
Mcdonald MM, Dulai S, Godfrey C, et al. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling [J]. Bone, 2008, 43(4): 653.
12
Li JL, Mori S, Kaji Y, et al. Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats [J]. J Bone Miner Res, 1999, 14(6): 969-979.
13
Bukata SV. Systemic administration of pharmacological agents and bone repair: what can we expect [J]. Injury, 2011, 42(6): 605-608.
14
Fu LJ, Tang TT, Hao YQ, et al. Long-term effects of alendronate on fracture healing and bone remodeling of femoral shaft in ovariectomized rats [J]. Acta Pharmacol Sin, 2013, 34(3): 387-392.
15
Solomon DH, Hochberg MC, Mogun H, et al. The relation between bisphosphonate use and non-union of fractures of the humerus in older adults [J]. Osteoporosis int, 2009, 20(6): 895-901.
16
Ha KY, Park KS, Kim SI, et al. Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing? [J]. Osteoporos Int, 2016, 27(2): 483-488.
17
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and Meta-Analyses: the PRISMA statement [J]. J Clin Epidemiol, 2009, 62 (10): 1006-1012.
18
Corrales LA, Morshed S, Bhandari M, et al. Variability in the assessment of fracture-healing in orthopaedic trauma studies [J]. J Bone Joint Surg Am, 2008, 90(9): 1862-1868.
19
Morshed S. Current options for determining fracture union [J]. Adv Med, 2014: 708574.
20
Higgins J, Altman DG, Sterne J. Chapter 8: Assessing risk of bias in included studies [M/OL]. Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017.

URL    
21
Deeks JJ HJ, Altman DG. Chapter 10: Analysing data and undertaking meta-analyses [M/OL]. Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019.

URL    
22
应伟奡.唑来膦酸对胸腰椎骨折愈合的影响[J].中国药房, 2015, (32): 4543.
23
高玉贵.阿仑膦酸钠联合碳酸钙D3对老年股骨粗隆间骨折患者术后骨折愈合及髋关节功能的影响[J].黑龙江医学, 2020, 44(9): 1222-1224.
24
Uchiyama S, Itsubo T, Nakamura K, et al. Effect of early administration of alendronate after surgery for distal radial fragility fracture on radiological fracture healing time [J]. Bone Joint J, 2013, 95-B(11): 1544-1550.
25
Dai Z. Effect of zoledronic acid on bone fusion after lumbar surgery for osteoporotic patients [J]. Spine J, 2014, 14(11): S32-S33.
26
奠伟,李章献,戴哲浩.唑来膦酸对骨质疏松症患者腰椎术后骨融合的影响[J].中国医师杂志, 2014, 16(8): 1039-1043.
27
Chen F, Dai Z, Kang Y, et al. Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion [J]. Osteoporos Int, 2016, 27(4): 1469-1476.
28
Uchiyama S, Itsubo T, Nakamura K, et al. Effect of alendronate on radiographic fracture healing after surgery for low-energy distal radius fracture s[J]. J Bone Miner Res, 2010, 25: S471.
29
Ralston S, Duckworth A, Tuck C, et al. Effect of alendronic acid on fracture healing-a randomised clinical trial [J]. J Bone Miner Res, 2017, 32: S296.
30
Duckworth AD, McQueen MM, Tuck CE, et al. Effect of Alendronic Acid on Fracture Healing: A Multicenter Randomized Placebo-Controlled Trial[J]. J Bone Miner Res, 2019,34(6):1025-1032.
31
Van DE, Van Engeland M, Adèr H, et al. Alendronate in the prevention of bone loss after a fracture of the lower leg [J]. J Bone Miner Res, 2002, 17(12): 2247.
32
Harding AK, W-Dahl A, Geijer M, et al. A single bisphosphonate infusion does not accelerate fracture healing in high tibial osteotomies [J]. Acta Orthop, 2011, 82(4): 465-470.
33
Colon-Emeric C, Nordsletten L, Olson S, et al. Association between timing of zoledronic acid infusion and hip fracture healing [J]. Osteoporos Int, 2011, 22(8): 2329-2336.
34
Nagahama K, Kanayama M, Togawa D, et al. Does alendronate disturb the healing process of posterior lumbar interbody fusion? A prospective randomized trial [J]. J Neurosurg Spine, 2011, 14(4): 500-507.
35
Kim TY, Yc H, Kang BJ, et al. Does early administration of bisphosphonate affect fracture healing in patients with intertrochanteric fractures? [J]. J Bone Joint Surg Br, 2012, 94(7): 956-960.
36
Gong HS, Song CH, Lee YH, et al. Early initiation of bisphosphonate does not affect healing nd outcomes of volar plate fixation of osteoporotic distal radial fractures [J]. J Bone Joint Surg Am Vol, 2012, 94(19): 1729-1736.
37
高勇,饶放萍,张万泉,等.阿仑膦酸钠联合辛伐他汀对老年髋部骨折内固定术后骨愈合的影响[J].中国当代医药, 2017, 24(33): 66-68, 84.
38
Yang L, Yang M. Early initiation of zoledronic acid does not impact bone healing or clinical outcomes of hallux valgus orthomorphia [J]. J Int Med Res, 2018, 46(8): 3251-3261.
39
Li C, Wang HR, Li XL, et al. The relation between zoledronic acid infusion and interbody fusion in patients undergoing transforaminal lumbar interbody fusion surgery [J]. Acta Neurochir (Wien), 2012, 154(4): 731-738.
40
潘晟.腰椎融合术后早期应用唑来膦酸的疗效分析[J].中国实用医药, 2014 (34): 158-159.
41
李辉南,杜文君,夏英鹏,等.绝经后骨质疏松患者腰椎融合术后早期应用唑来膦酸的疗效分析[J].中国妇幼保健, 2016, 31(14): 2829-2831.
42
Liu B, Liu X, Chen Y, et al. Clinical effect observation of intravenous application of zoledronic acid in patients with cervical spondylosis and osteoporosis after anterior cervical discectomy and fusion: A randomized controlled study [J]. J Orthop Surg (Hong Kong), 2019, 27(2): 2309499019847028.
43
陈莹,盛珺,刘达,等.唑来膦酸改善骨质疏松患者后路腰椎椎间融合术后腰痛[J].脊柱外科杂志, 2019, 17(5): 319-323.
44
刘汉辉,刘鹄,李辉.唑来膦酸联合椎间孔椎体间融合术治疗老年腰椎滑脱伴骨质疏松的疗效[J].中国老年学杂志, 2019, 39(7): 1640-1643.
45
尹自龙,石磊,张啓维,等.唑来膦酸对颈椎前路椎间盘切除椎间融合术后的疗效观察[J].中国临床医生杂志, 2020, 48(4): 462-466.
46
Van DE, Patka P, Vandormael K, et al. The effect of alendronate on bone mass after distal forearm fracture [J]. J Bone Miner Res, 2000, 15(3): 586.
47
Thomas J, Kneale D, McKenzie JE, et al. Chapter 2: Determining the scope of the review and the questions it will address [M/OL]. Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019).

URL    
48
Einhorn TA. The cell and molecular biology of fracture healing [J]. Clin Orthop Relat Res, 1998 (355, S): S7-S21.
49
Goldhahn J, Little D, Mitchell P, et al. Evidence for anti-osteoporosis therapy in acute fracture situations--recommendations of a multidisciplinary workshop of the International Society for Fracture Repair [J]. Bone, 2010, 46(2): 267-271.
50
Giannoudis PV, Einhorn T, Marsh D. Fracture healing: the diamond concept [J]. Injury, 2007, 38 Suppl 4: S3-S6.
51
Hao Y, Wang X, Wang L, et al. Zoledronic acid suppresses callus remodeling but enhances callus strength in an osteoporotic rat model of fracture healing [J]. Bone, 2015, 81: 702-711.
52
Manabe T, Mori S, Mashiba T, et al. Eel calcitonin (elcatonin) suppressed callus remodeling but did not interfere with fracture healing in the femoral fracture model of cynomolgus monkeys [J]. J Bone Miner Metab, 2009, 27(3): 295-302.
53
Amanat N, Mcdonald M, Godfrey C, et al. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair [J]. J Bone Miner Res, 2007, 22(6): 867-876.
54
Li J, Mori S, Kaji Y, et al. Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats [J]. J Bone Miner Res, 2000, 15(10): 2042-2051.
55
Edwards BJ, Bunta AD, Lane J, et al. Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project [J]. J Bone Joint Surg Am, 2013, 95(4): 297-307.
56
Adami S, Libanati C, Boonen S, et al. Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial [J]. J Bone Joint Surg Am, 2012, 94(23): 2113-2119.
[1] 蚁淳, 袁冬生, 熊学军. 系统免疫炎症指数与骨密度降低和骨质疏松的关联[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 609-617.
[2] 李志文, 李远志, 李华, 方志远. 糖皮质激素治疗膝骨关节炎疗效的网状Meta分析[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 484-496.
[3] 吴姗姗, 潘裕民, 刘晋, 张劲松, 乔莉. 睡眠呼吸暂停综合征患者静脉血栓栓塞症发生率的Meta分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 312-317.
[4] 程鹏, 杨道鸿, 邓文君, 钟宇琼, 胡晓雪, 黄小银, 周道扬. 纤维蛋白原治疗创伤性凝血病有效性和安全性的Meta分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(03): 225-231.
[5] 沈皓, 张驰, 韩旻轩, 陆晓庆, 周愉, 周莉丽. 骨皮质切开术对正畸治疗牙根吸收影响的Meta分析[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(03): 175-184.
[6] 郭仁凯, 武慧铭, 李辉宇. 机器人辅助全系膜切除术治疗右半结肠癌有效性和安全性的Meta分析及试验序贯分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(03): 234-240.
[7] 朱俊佳, 孙琦, 徐文龙, 陆天宇, 冯强, 储涛, 邢春根, 高春冬, 俞一峰, 赵振国. 永久性结肠造口预防性补片置入对预防造口旁疝价值的Meta分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(03): 336-342.
[8] 王招荐, 曹桢, 郭小双, 靳小雷, 刘子文. 加速康复外科理念应用于腹壁重建手术的系统评价及Meta分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(03): 343-350.
[9] 马振威, 宋润夫, 王兵. ERCP胆道内支架与骑跨十二指肠乳头支架置入治疗不可切除肝门部胆管癌疗效的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 807-812.
[10] 龚财芳, 赵俊宇, 游川. 围手术期肠内营养在肝癌肝切除患者中有效性及安全性的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 551-556.
[11] 刘蕊, 李乐, 陈金明, 李鑫. 急性胆管炎严重程度与血清标志物相关性的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 176-181.
[12] 郁凯, 曾保起, 杨剑, 杨杰, 张殿英, 孙凤. 全关节镜与切开手术治疗肩袖撕裂疗效比较的系统综述与Meta分析[J/OL]. 中华肩肘外科电子杂志, 2024, 12(03): 238-245.
[13] 王芳, 刘达, 左智炜, 盛金平, 陈庭进, 蒋锐. 定量CT与双能X线骨密度仪对骨质疏松诊断效能比较的Meta分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 363-371.
[14] 周倩妹, 王宪娥, 徐筱, 老慧琳, 赵欣悦, 胡菁颖. 多元化系统护理对老年人群牙周健康指标影响的系统评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 500-506.
[15] 王学建, 汪志峰, 钱明, 姜雷, 宋校伟, 胡伟梁. 比较神经内镜与钻孔引流对慢性硬膜下血肿疗效的Meta分析[J/OL]. 中华卫生应急电子杂志, 2024, 10(02): 65-69.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号